DESIPRAMINE Drug Patent Profile

Which patents cover Desipramine, and when can generic versions of Desipramine launch?

Desipramine is a drug marketed by Actavis Totowa, Alembic, Amneal Pharms Co, Ani Pharms, Chartwell Rx, Heritage, Ingenus Pharms Llc, and Usl Pharma. and is included in sixteen NDAs.

The generic ingredient in DESIPRAMINE is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Desipramine

A generic version of DESIPRAMINE was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5^th, 1987.

Summary for DESIPRAMINE

US Patents:	0
Applicants:	8
NDAs:	16
Drug Prices:	Drug price information for DESIPRAMINE
DailyMed Link:	DESIPRAMINE at DailyMed

See drug prices for DESIPRAMINE

US Patents and Regulatory Information for DESIPRAMINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	207433-006	May 5, 2016		DISCN	No	No
Chartwell Rx	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	072103-004	May 24, 1988	AB	RX	No	No
Usl Pharma	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071865-001	Sep 9, 1987		DISCN	No	No
Ingenus Pharms Llc	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	204963-004	Dec 26, 2017	AB	RX	No	No
Usl Pharma	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071866-001	Sep 9, 1987		DISCN	No	No
Ani Pharms	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071803-005	May 29, 1997		DISCN	No	No
Chartwell Rx	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	072103-005	Jun 20, 1988	AB	RX	No	No